"St. Louis Children’s Hospital is dedicated to improving the health and lives of children. As one of the top-ranked children’s hospitals in the country, St. Louis Children’s Hospital provides care in more than 50 specialty areas through a dedicated team of physicians, nurses, staff and volunteers. Along with inpatient and outpatient medical care, the hospital offers education, wellness and injury-prevention programs to fulfill its mission to “do what’s right for kids.”"

During the past decade, Washington University/St. Louis Children's Hospital conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 19 clinical trials were completed, i.e. on average, 54.3% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 9 clinical trials were completed. i.e. 45% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Washington University/St. Louis Children's Hospital" #1 sponsor was "Vertex Pharmaceuticals Incorporated" with 11 trials, followed by "Medical College of Wisconsin" with 6 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials sponsored, "Washington University School of Medicine" with 4 trials sponsored and "Center for International Blood and Marrow Transplant Research" with 4 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Washington University/St. Louis Children's Hospital" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 10 trials as a collaborator, "National Marrow Donor Program" with 8 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 6 trials as a collaborator, "National Cancer Institute (NCI)" with 6 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 4 trials as a collaborator. Other collaborators include 54 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Washington University/St. Louis Children's Hospital" are "Cystic Fibrosis" (14 trials), "Sickle Cell Disease" (5 trials), "Rett Syndrome" (3 trials), "Childhood Cancer" (2 trials) and "Early-Onset Scoliosis Deformity of Spine" (2 trials). Many other conditions were trialed in "Washington University/St. Louis Children's Hospital" in a lesser frequency.

Most popular intervention types in "Washington University/St. Louis Children's Hospital" are "Drug" (30 trials), "Device" (8 trials), "Other" (6 trials), "Biological" (5 trials) and "Behavioral" (4 trials). Other intervention types were less common.

The name of intervention was led by "IVA" (10 trials), "Placebo" (7 trials), "ELX/TEZ/IVA" (6 trials), "VX-659/TEZ/IVA" (3 trials) and "Busulfan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Washington University/St. Louis Children's Hospital" are 57 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 26 active trials in "Washington University/St. Louis Children's Hospital". 2 are not yet recruiting, 15 are recruiting, 5 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 31 completed trials in Washington University/St. Louis Children's Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Washington University/St. Louis Children's Hospital, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".